Lung Cancer

Matthew D. Hellmann MD and Heather Wakelee MD review and share their expert perspectives on key lung cancer findings presented at the 2017 American Society of Clinical Oncology Annual Meeting.

Share

Program Content

Activities

  • KEYNOTE-021 Cohort G
    Pembrolizumab + Carboplatin and Pemetrexed in Previously Untreated, Advanced Nonsquamous NSCLC: Updated Results From KEYNOTE-021 Cohort G
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 04, 2017

    Expires: June 03, 2018

  • nab-P/carbo in High-Risk NSCLC
    nab-Paclitaxel + Carboplatin in Higher-Risk Pt Populations With Advanced NSCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2017

    Expires: June 04, 2018

  • irAEs With Immunotx Retreatment
    Retrospective Analysis of Immunotherapy Retreatment Following Immune-Related AEs in NSCLC Pts Treated With Anti–PD-(L)1 Therapy
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2017

    Expires: June 04, 2018

  • ADJUVANT: Gefitinib in <i>EGFR</i>mut+ NSCLC
    ADJUVANT: Phase III Trial Evaluating Gefitinib vs Vinorelbine/Cisplatin in Completely Resected Stage II-IIIA (N1-N2) NSCLC With EGFR Activating Mutations
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2017

    Expires: June 06, 2018

  • CheckMate 032: Nivo/Ipi in SCLC
    Phase I/II CheckMate 032: Nivolumab ± Ipilimumab in Advanced SCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2017

    Expires: June 06, 2018

  • Post-PD Atezolizumab in NSCLC
    OAK: Impact of Continued Atezolizumab Beyond PD in Pts With Advanced NSCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 07, 2017

    Expires: June 06, 2018

  • KEYNOTE-024 Update
    KEYNOTE-024: Extended Survival Outcomes With First-line Pembrolizumab in PD-L1+ NSCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2017

    Expires: June 07, 2018

  • ALEX: Alectinib in <i>ALK</i>+ NSCLC
    ALEX: Alectinib vs Crizotinib as First-line Therapy in Pts With ALK+ NSCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 08, 2017

    Expires: June 07, 2018

  • Osimertinib CNS response
    AURA-3: CNS Response to Osimertinib in EGFR T790M+ Advanced NSCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 09, 2017

    Expires: June 08, 2018

  • ARCHER 1050
    ARCHER 1050: First-line Dacomitinib vs Gefitinib in EGFR-Mutant Advanced NSCLC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 09, 2017

    Expires: June 08, 2018

  • Recurrent MPM: Nivo ± Ipi
    MAPS-2 (IFCT-1501): Nivolumab ± Ipilimumab in Recurrent Malignant Pleural Mesothelioma
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

AbbVie

Amgen, Inc.

AstraZeneca

Celgene

Genentech Roche Virology

Halozyme

Incyte

Merck Oncology